Use and reporting of patient-reported outcomes in randomized controlled trials in non-Hodgkin lymphoma: a scoping review

Key Points

• Patient-reported outcomes are often underutilized in trials assessing non-Hodgkin lymphoma.
• The review highlights gaps in reporting these outcomes, which affects data quality.
• Observational analysis across a range of trials reveals inconsistencies in methodology and measurement.
• This work calls for improved guidelines to standardize the use of patient-reported outcomes in clinical research.